Musculoskeletal Cancers Remote Monitoring and Care

This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.

Trial Details

NCT ID
NCT07129226
Phase
NA
Sponsor
Case Comprehensive Cancer Center
Status
RECRUITING
Cancer Type
Sarcoma
Interventions
  • Smart Watch
Locations (sample)
  • Cleveland, Ohio, United States|41.4995,-81.69541

Key Eligibility Criteria

  • primary sarcoma or metastatic bone disease of the lower extremities or pelvis.
  • undergoing evaluation for (or have recently undergone) non-surgical or surgical intervention.
  • recent history of home ambulation.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Sarcoma Trials on Trialify →